Mail

Canada markets closed

S&P/TSX
22,465.37
+165.54(+0.74%)
S&P 500
5,303.27
+6.17(+0.12%)
DOW
40,003.59
+134.21(+0.34%)
CAD/USD
0.7348
+0.0002(+0.03%)
CRUDE OIL
80.00
+0.77(+0.97%)
Bitcoin CAD
91,078.02
+1,982.99(+2.23%)

MARKETS LIVE BLOG

DOW CROSSES 40,000 MARK FOR THE FIRST TIME

All three major indices post weekly wins as meme rally fizzles out

Fusion Pharmaceuticals Inc. (FUSN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

21.51

+0.05

(+0.23%)

At close: 04:00PM EDT

21.51

0.00

(0.00%)

After hours:

04:20PM EDT

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	1.83B
Enterprise Value	1.68B
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	769.11
Price/Book (mrq)	7.55
Enterprise Value/Revenue	823.24
Enterprise Value/EBITDA	-0.38

Trading Information

Stock Price History

Beta (5Y Monthly)	N/A
52-Week Change ³	400.23%
S&P500 52-Week Change ³	26.36%
52 Week High ³	21.58
52 Week Low ³	2.31
50-Day Moving Average ³	19.50
200-Day Moving Average ³	9.41

Share Statistics

Avg Vol (3 month) ³	1.95M
Avg Vol (10 day) ³	379.43k
Shares Outstanding ⁵	85.06M
Implied Shares Outstanding ⁶	85.06M
Float ⁸	63.44M
% Held by Insiders ¹	0.47%
% Held by Institutions ¹	86.34%
Shares Short (Apr 30, 2024) ⁴	3.95M
Short Ratio (Apr 30, 2024) ⁴	3.65
Short % of Float (Apr 30, 2024) ⁴	5.45%
Short % of Shares Outstanding (Apr 30, 2024) ⁴	4.64%
Shares Short (prior month Mar 28, 2024) ⁴	5.2M

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Mar 31, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	-5,403.78%

Management Effectiveness

Return on Assets (ttm)	-23.34%
Return on Equity (ttm)	-47.11%

Income Statement

Revenue (ttm)	2.04M
Revenue Per Share (ttm)	0.03
Quarterly Revenue Growth (yoy)	N/A
Gross Profit (ttm)	N/A
EBITDA	-108.8M
Net Income Avi to Common (ttm)	-104.28M
Diluted EPS (ttm)	-1.40
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	210.52M
Total Cash Per Share (mrq)	2.47
Total Debt (mrq)	64.55M
Total Debt/Equity (mrq)	26.69%
Current Ratio (mrq)	10.64
Book Value Per Share (mrq)	2.85

Cash Flow Statement

Operating Cash Flow (ttm)	-83.67M
Levered Free Cash Flow (ttm)	-58.48M